Thermo Fisher Scientific Inc. (LON:0R0H)
London
· Delayed Price · Currency is GBP · Price in USD | Market Cap | 134.91B |
| Revenue (ttm) | 31.51B |
| Net Income (ttm) | 4.80B |
| Shares Out | n/a |
| EPS (ttm) | 12.61 |
| PE Ratio | 28.10 |
| Forward PE | 20.71 |
| Dividend | 1.25 (0.26%) |
| Ex-Dividend Date | Jun 13, 2025 |
| Volume | 451 |
| Average Volume | 1,591 |
| Open | 480.78 |
| Previous Close | 477.53 |
| Day's Range | 479.48 - 485.54 |
| 52-Week Range | 385.88 - 627.50 |
| Beta | 0.75 |
| RSI | 62.69 |
| Earnings Date | Jul 23, 2025 |
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar... [Read more]
Financial Performance
In 2024, Thermo Fisher Scientific's revenue was $42.88 billion, an increase of 0.05% compared to the previous year's $42.86 billion. Earnings were $6.34 billion, an increase of 5.67%.
Financial numbers in USD Financial StatementsNews
Trade tracker: Bill Baruch buys Thermo Fisher
Bill Baruch, founder and president at Blue Line Capital, joins CNBC's “Halftime Report” to explain why he's buying Thermo Fisher here.
Trade tracker: Bill Baruch buys Thermo Fisher
Bill Baruch, founder and president at Blue Line Capital, joins CNBCs Halftime Report to explain why he's buying Thermo Fisher here.
Thermo Fisher Posts 3% Q2 Rise
Unpacking the Latest Options Trading Trends in Thermo Fisher Scientific
Deep-pocketed investors have adopted a bearish approach towards Thermo Fisher Scientific (NYSE: TMO), and it's something market players shouldn't ignore. Our tracking of public options records at Ben...
Thermo Fisher Scientific Showcases Diagnostics Solutions Designed to Meet Evolving Global Healthcare Demands at ADLM 2025
CHICAGO--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, showcases its innovations in improving clinical and diagnostic laboratory efficiency and workflow optimization ...
Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week (July 21-July 25): Are The Others In Your Portfolio?
Medpace, ICON, and West Pharma led ... Full story available on Benzinga.com
Notable healthcare headlines for the week: Pfizer, UnitedHealth, Sarepta and Thermo Fisher in focus
Thermo Fisher Scientific Increases Accessibility to Research With the Launches of Scios 3 and Talos 12 Electron Microscopes at M&M 2025 Conference
WALTHAM, Mass.--(BUSINESS WIRE)--As the world leader in serving science, Thermo Fisher Scientific is proud to announce the launch of two new electron microscopes that will be unveiled at Microscopy & ...
Thermo Fisher Posts 3% Q2 Revenue Gain
Crude Oil Falls; Thermo Fisher Scientific Earnings Top Views
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 350 points on Wednesday. The Dow traded up 0.82% to 44,869.16 while the NASDAQ rose 0.16% to 20,925.86. The...
Why Thermo Fischer Stock Is Rising Wednesday
Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday reported second-quarter 2025 adjusted earnings of $5.36 per share, beating the street view of $5.23 . Quarterly sales of $10.86 billion increase...
Why Thermo Fisher Stock Is Rising Wednesday
Thermo Fisher Scientific Inc. TMO on Wednesday reported second-quarter 2025 adjusted earnings of $5.36 per share, beating the street view of $5.23.
Thermo Fisher Scientific Stock Jumps on Strong Results, Higher Outlook
Thermo Fisher Scientific beat profit and sales estimates on organizational discipline.
Earnings: A snapshot of Thermo Fisher Scientific’s (TMO) Q2 2025 report
Thermo Fisher Scientific Inc. (NYSE: TMO), a global leader in life sciences, on Wednesday announced financial results for the second quarter of fiscal 2025, reporting an increase in revenues and […] T...
GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Dow Jones index gaining around 200 points on Wednesday. Shares of GE Vernova Inc . (NYSE: GEV) rose sharply during Wednesday's session after the company posted bette...
Thermo Fisher raises 2025 guidance to $44.2B revenue and $22.84 EPS amid strong pharma and biotech momentum
Thermo Fisher Scientific Inc. (TMO) Q2 2025 Earnings Call Transcript
Thermo Fisher Scientific's Chief Financial Officer, Stephen Williamson, to Retire in Early 2026
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that Stephen Williamson, senior vice president and chief financial offi...
Thermo Fisher gains as life sciences and lab products units drive Q2 beat
Thermo Fisher beats quarterly estimates on resilient demand for its tools and services
Thermo Fisher on Wednesday beat Wall Street estimates for second-quarter profit and revenue, helped by steady demand for its products and services used for developing therapies.
Thermo Fisher Scientific Profit, Revenue Rise
Thermo Fisher Scientific Non-GAAP EPS of $5.36 beats by $0.12, revenue of $10.86B beats by $180M
Thermo Fisher Scientific reports strong Q2 results with EPS of $5.36 and $10.86B revenue.
Thermo Fisher Scientific Reports Second Quarter 2025 Results
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 28, 2025. Second...
Earnings Scheduled For July 23, 2025
Companies Reporting Before The Bell • Equinor (NYSE: EQNR) is projected to report quarterly earnings at $0.26 per share on revenue of $24.67 billion. • Thermo Fisher Scientific (NYSE: TMO) is expect...